Sales 2024 * | 120M 9.46B | Sales 2025 * | 130M 10.25B | Capitalization | 96.08M 7.57B |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.26B | Net income 2025 * | 1M 78.78M | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
-5.94
x | P/E ratio 2025 * |
202
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.77% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 31/01/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 30/06/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 05/03/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 31/10/03 |
James Tyree
BRD | Director/Board Member | 71 | 30/09/16 |
William McKee
BRD | Director/Board Member | 62 | 28/02/17 |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |